A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)

Project: Other project

Project Details

StatusFinished
Effective start/end date7/28/14 → 7/27/16

Funding

  • EMD Serono Inc: $6,000.00